Medikit Co.,Ltd. (TYO:7749)
Japan · Delayed Price · Currency is JPY 2,860.00
-21.00 (-0.73%)
Sep 15, 2026, 9:00 AM JST
Medikit Ratios and Metrics
Market cap in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 14, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 41,711 | 43,304 | 38,237 | 50,387 | 41,010 | 39,117 | |
Market Cap Growth | 4.58% | 13.25% | -24.11% | 22.86% | 4.84% | -28.60% |
Enterprise Value | 21,734 | 23,166 | 17,965 | 22,925 | 15,034 | 12,184 |
Last Close Price | 2881.00 | 2991.00 | 2524.80 | 2803.40 | 2220.10 | 2029.53 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 14, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 13.35 | 14.41 | 12.69 | 16.42 | 14.32 | 13.07 |
Forward PE | - | 20.81 | 20.81 | 20.81 | 20.81 | 20.81 |
PS Ratio | 1.72 | 1.82 | 1.70 | 2.31 | 1.90 | 1.94 |
PB Ratio | 0.89 | 0.93 | 0.85 | 1.14 | 0.87 | 0.86 |
P/TBV Ratio | 0.95 | 0.99 | 0.91 | 1.24 | 0.93 | 0.86 |
P/FCF Ratio | 32.26 | 33.49 | - | 16.02 | 11.73 | 28.47 |
P/OCF Ratio | 8.81 | 9.15 | 10.74 | 10.42 | 9.15 | 12.41 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 14, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 0.90 | 0.97 | 0.80 | 1.05 | 0.70 | 0.61 |
EV/EBITDA Ratio | 3.27 | 3.67 | 2.91 | 3.69 | 2.77 | 2.14 |
EV/EBIT Ratio | 4.81 | 5.42 | 4.01 | 4.90 | 3.65 | 2.76 |
EV/FCF Ratio | 16.81 | 17.92 | - | 7.29 | 4.30 | 8.87 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 14, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / EBITDA Ratio | 0.00 | 0.00 | - | - | - | - |
Debt / FCF Ratio | - | 0.01 | - | - | - | - |
Net Debt / Equity Ratio | -0.43 | -0.45 | -0.48 | -0.53 | -0.58 | -0.61 |
Net Debt / EBITDA Ratio | -3.01 | -3.32 | -3.49 | -3.80 | -5.07 | -4.94 |
Net Debt / FCF Ratio | - | -16.19 | 84.22 | -7.50 | -7.89 | -20.46 |
Asset Turnover | 0.47 | 0.45 | 0.44 | 0.42 | 0.42 | 0.40 |
Inventory Turnover | 2.90 | 2.94 | 3.29 | 3.66 | 3.85 | 3.26 |
Quick Ratio | 5.05 | 4.91 | 4.32 | 5.05 | 7.12 | 7.50 |
Current Ratio | 6.52 | 6.25 | 5.40 | 6.03 | 8.17 | 8.73 |
Return on Equity (ROE) | 6.86% | 6.54% | 6.75% | 6.71% | 6.16% | 6.69% |
Return on Assets (ROA) | 5.41% | 5.05% | 5.42% | 5.61% | 4.93% | 5.47% |
Return on Invested Capital (ROIC) | 11.43% | 11.51% | 13.15% | 14.95% | 14.71% | 17.50% |
Return on Capital Employed (ROCE) | 9.40% | 8.90% | 9.70% | 10.30% | 8.50% | 9.50% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 14, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 7.52% | 6.94% | 7.88% | 6.09% | 6.98% | 7.65% |
FCF Yield | 3.10% | 2.99% | -0.67% | 6.24% | 8.53% | 3.51% |
Dividend Yield | 3.36% | 3.34% | 3.56% | 2.85% | 3.15% | 2.96% |
Payout Ratio | - | 46.84% | 44.08% | 57.05% | 52.69% | 27.87% |
Buyback Yield / Dilution | 1.06% | 1.13% | 9.79% | 2.70% | 0.10% | 0.57% |
Total Shareholder Return | 4.42% | 4.47% | 13.36% | 5.55% | 3.25% | 3.52% |